Related Experiment Video
Updated: Aug 14, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
Predictors of Cardiovascular Events After Liver Transplantation
Juan F Gallegos-Orozco1, Michael R Charlton2
1Division of Gastroenterology, Hepatology and Nutrition, University of Utah School of Medicine, 30 North 1900 East SOM 4R118, Salt Lake City, UT 84132, USA.
Insights
Liver transplant recipients, often older and sicker, face risks from cardiovascular disease. Pretransplant evaluation is crucial for identifying and mitigating these cardiac risks to improve patient outcomes.
Area of Science:
- Cardiology
- Hepatology
- Transplantation Medicine
Background:
- Liver transplant indications have expanded, leading to increased transplantation in older, sicker patients.
- Post-transplant mortality is significantly influenced by infectious, malignant, and cardiovascular diseases.
- Cirrhosis can lead to various forms of heart disease, complicating patient management.
Purpose of the Study:
- To highlight the increased cardiovascular risks in liver transplant candidates.
- To emphasize the importance of pretransplant cardiovascular evaluation.
- To identify key risk factors for post-transplant cardiovascular complications.
Main Methods:
- Review of existing literature on liver transplantation and cardiovascular complications.
- Analysis of risk factors associated with post-transplant mortality.
- Identification of diagnostic tools for cardiovascular assessment in cirrhotic patients.
Main Results:
- Cardiovascular disease is a leading cause of death after liver transplantation.
- A history of cardiovascular disease and specific cardiac test abnormalities increase risk.
- No single factor reliably predicts post-transplant cardiovascular complications.
Conclusions:
- Pretransplant cardiovascular evaluation is essential for liver transplant candidates.
- Identifying and managing pre-existing cardiac conditions can mitigate post-transplant risks.
- Comprehensive cardiac assessment is vital for improving outcomes in liver transplant recipients.
Abstract:
Indications for liver transplant have been extended, and older and sicker patients are undergoing transplantation. Infectious, malignant, and cardiovascular diseases account for the most posttransplant deaths. Cirrhotic patients can develop heart disease through systemic diseases affecting the heart and the liver, cirrhosis-specific heart disease, or common cardiovascular. No single factor can predict posttransplant cardiovascular complications. Patients with history of cardiovascular disease, and specific abnormalities on echocardiography, electrocardiography, or serum markers of heart disease seem to be at increased risk of complications. Pretransplant cardiovascular evaluation is essential to detecting these risk factors so their effects can be mitigated through appropriate intervention.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Kidney Transplant I: Introduction

